Compare BioAxone Therapeutique vs Lead Therapeutics
Customers evaluate the quality of BioAxone Therapeutique's products using the following success metrics.
Overview
BioAxone Therapeutique is 24 yrs old and is based in Canada.
BioAxone is a privately owned neuroscience company engaged in the development and commercialization of technologies that target Rho signaling. Established in April 2000 and headquartered in Montreal, Canada, BioAxone has demonstrated expertise in recombinant protein product development and has a focused small molecule program.
Lead Therapeutics is 18 yrs old and is based in United States.
LEAD Therapeutics, Inc. is a chemistry-driven drug discovery company focused on delivering novel and differentiated small molecule pre-IND candidates against clinically validated therapeutic targets by leveraging the best of the US and China. Headquartered in the San Francisco Bay Area, LEAD Therapeutics is led by an experienced small molecule drug discovery team with proven track records in the pharmaceutical and biotech industries. The company plans to carry out the majority of its discovery research activities in China.
Demo Video
Leadership
Frank Bobe (Chief Executive Officer, President)
Leonard Post (Founder)
Investors
Pappas Ventures, ProQuest Investments
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because BioAxone Therapeutique has not claimed their profile.
Work for BioAxone Therapeutique? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for BioAxone Therapeutique?
Claim your profile now.
Information not available because Lead Therapeutics has not claimed their profile.
Work for Lead Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Lead Therapeutics?
Claim your profile now.